DRKS00020523CompletedNot Applicable
Post-Market Clinical Follow-up (PMCF) Study with the MOBIS II ST cage-implant for transforaminal lumbar fusion (TLIF) - PMCF MOBIS II ST
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- SIGNUS Medizintechnik GmbH
- Enrollment
- 57
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Patients who are implanted routinely and in accordance with the certification of MOBIS II ST
Exclusion Criteria
- •- Pregnant and breastfeeding women
- •- Patients incapable of giving consent
- •- Younger than 18 years old
- •- Patients without informed consent
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A study to assess the safety and efficacy of hyaluronic acid dermal fillers in the treatment of facial agingISRCTN17960592Sinclair Pharmaceuticals Limited168
Active, not recruiting
Phase 3
A post-market clinical follow-up study of Perfectha Subskin LidocaineA range of Fitzpatrick skin types presenting significant loss of volume in the cheeks, jawline and/or chinSkin and Connective Tissue DiseasesISRCTN63865080Sinclair Pharma69
Recruiting
Phase 4
To study the effectiveness of surgical treatment in patients with knee joint paiCTRI/2023/12/060753Auxein Medical Pvt Ltd
Completed
Not Applicable
Post-market clinical follow-up (PMCF) study to investigate the percentage of relapses in treatment with KadeFungin® Milchsäurekur and its tolerability in female patients suffering from recurrent urinary tract infectioN39.0N30.2Urinary tract infection, site not specifiedOther chronic cystitisDRKS00016760DR. KADE Pharmazeutische Fabrik GmbH81
Completed
Not Applicable
Post-market clinical follow-up (PMCF) study to observe the course of symptoms of vulvovaginal dryness in patients receiving therapy with KadeFungin® BefeuchtungsgelN89.8Other specified noninflammatory disorders of vaginaDRKS00017248DR. KADE Pharmazeutische Fabrik GmbH100